CHRU Jean Minjoz

Besançon, Doubs 25030

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03] — Running, not enrolling